On Monday, Shares of Novocure Ltd (NASDAQ:NVCR), gained 23.12% to $25.88. The stock attained the volume of 2.13 million shares.
Novocure (NVCR) declared that the U.S. Food and Drug Administration (FDA) has approved Optune in combination with temozolomide for the treatment of adult patients with newly diagnosed glioblastoma (GBM). Optune is a portable, non-invasive device that delivers low-intensity, intermediate frequency, alternating electric fields – referred to as Tumor Treating Fields (TTFields) – that inhibit cancer cell replication and cause cancer cell death.
Optune is the first FDA-approved therapy in more than a decade to demonstrate statistically noteworthy extension of overall survival in newly diagnosed GBM. The two-year survival rate among patients treated with Optune in combination with temozolomide was 50% higher than in patients treated with temozolomide alone. No noteworthy additive systemic toxicity was observed in the trial, and patients maintained stable quality-of-life, cognitive function and activities of daily living while using Optune.
The FDA approval follows a preceding review of the Optune Premarket Approval (PMA) supplement application. The FDA grants preceding review status to medical devices that are intended to treat life-threatening diseases and that offer clinically meaningful advantages over existing approved alternatives. Optune was formerly approved in April 2011 for the treatment of adult patients with GBM following tumor recurrence after receiving chemotherapy.
NovoCure Limited develops and commercializes treatment for solid tumor cancers therapy called the tumor treating fields (TTFields). The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients with glioblastoma brain cancer.
Shares of Marsh & McLennan Companies, Inc. (NYSE:MMC), surged 0.88% to $53.92, during its last trading session.
The stock saw its price movement on above -normal volume, as 2.36 million shares changed hands when contrast with its average daily volume of 2.23 million shares, with a year-to-date performance of -3.78%.
11 analysts have set the short term price target of Marsh & McLennan Companies, Inc. (NYSE:MMC) at $61.64. The standard deviation of short term price target has been estimated at $2.8, implying that the actual price may fluctuate by this value. The higher and the lower price estimates are $ 66 and $57 respectively.
Marsh & McLennan Companies, Inc., a professional services firm, provides advice and solutions primarily in the areas of risk, strategy, and people worldwide. It operates in two segments, Risk and Insurance Services; and Consulting.
Finally, Ross Stores, Inc. (NASDAQ:ROST), ended its last trade with 3.04% gain, and closed at $50.53.
Ross Stores declared the opening of 19 Ross Dress for Less® and seven dd’s DISCOUNTS® stores across 14 different states in September and October. These new locations complete the Company’s 2015 expansion plans to add a total of 90 stores during the year.
Ross Stores, Inc. is an S&P 500, Fortune 500 and NASDAQ 100 (ROST) company headquartered in Dublin, California, with fiscal 2014 revenues of $11.0 billion. Presently, the Company operates Ross Dress for Less®, the largest off-price apparel and home fashion chain in the United States with 1,276 locations in 34 states, the District of Columbia and Guam.
Ross offers first-quality, in-season, name brand and designer apparel, accessories, footwear and home fashions for the entire family at savings of 20% to 60% off department and specialty store regular prices every day. The Company also presently operates 172 dd’s DISCOUNTS® in 15 states that feature a more moderately-priced assortment of first-quality, in-season, name brand apparel, accessories, footwear and home fashions for the entire family at savings of 20% to 70% off moderate department and discount store regular prices every day.
Ross Stores, Inc., together with its auxiliaries, operates off-price retail apparel and home fashion stores under the Ross Dress for Less and dd’s DISCOUNTS brand names in the United States.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
